Published :
Tables : 400
Figures : 37
Category : Healthcare
No. of Pages : 300
Report Code : HC-1161
Infection Control Market Introduction: Infection Control Market to value over USD 54.3 billion and register a CAGR of over 3.2% during the forecast period of 2020-2027. The rise in geriatric population along with the widening prevalence of chronic diseases due to lifestyle changes, sedentary habits, unhealthy dietary routines will drive future market growth. The population is thus more prone to acquiring infections due to the presence of a combination of increased comorbid condition and decreasing efficiency of the immune system. The increasing frequency of surgical procedures coupled with the growing incidence of nosocomial infections will boost infection control market growth during the forecast period. Considering the statistics by WHO, 10 out of every 100 individuals hospitalized globally in developing countries and 7 in developed countries are likely to acquire nosocomial infections. The statistics accurately reflect the swelling need for the market’s products and services. The market is classified into products & services, end-users, and region. In the products and services segment, the market is anticipated to grow at a lucrative rate throughout the forecast period. This accelerated increase is attributed to the high affinity of market players to diminish overall healthcare expenditure along maximizing patient benefits. In context to end-users, hospitals and clinics held a principal share and are predicted to achieve growth at the highest CAGR throughout the forecast period. The substantial share is majorly a consequence of high probability of acquiring infections in hospital premises through respiratory or bloodborne pathogen transmission. Based on the region, the Asia Pacific market is presumed to register the fastest growth during the projected time period with the surge in healthcare expenditure and superlative healthcare standards and infrastructure. Boost in the number of outsourcing organizations in the region will benefit the market in the forthcoming years. A voluntary organization, Asia Pacific Society of Infection Control (APSIC) entertains collaborations and partnerships as well as infection control research to promote cost-efficient practices throughout the region. The regional market also gains momentum on the back of various government organizations committed to elevating the standards for infection control. Impact of COVID-19 on Infection Control Market: According to WHO, the transmission of the COVID-19 is through respiratory droplets, i.e. droplets that are larger than 5 micrometers of diameter, and through contact route. With countries like India going under complete lockdown, the transmission of infection shall be curbed down significantly. Furthermore, hospitals are providing optimum healthcare services like creation of isolation wards for the infected patients, using PPE kits to treat the infected patients whilst avoiding getting infected. They also use EPA-certified surface disinfectants to clean the hospital premises. Major industry players include: 3M Company, Belimed, Ahlstrom Corporation, Johnson & Johnson, Sterigenics International, Kimberly Clark Corporation, Steris, Getinge Group, Matachana Group, Cantel Medical Corporation. Competitive Landscape: The major market players adopt strategies of mergers, acquisitions, and new product launches in order to strengthen their market position and establish a global foothold in the market Nelson Laboratories, a division of Sotera Health (US), acquired Gibraltar Laboratories (US). This strengthened the portfolio of infection control test services for pharmaceutical and medical device manufacturing companies Cantel Medical (US) launched ADVANTAGE PLUS Pass-Thru Automated Endoscope Reprocessor, which thus expanded the market and product portfolio Sotera Health (US) signed an agreement with Noxilizer (US), which gave Sterigenics the exclusive rights for the worldwide distribution of NO2 contract sterilization products and services to the pharmaceutical, biotechnology, and medical device manufacturing industries Infection Control Market Segmentation: By Product & Service • Sterilization Products and Services o Sterilization Equipment • Heat Sterilization Equipment o Moist Heat Sterilizers o Dry Heat Sterilizers • Low-Temperature Sterilization o Hydrogen Peroxide Sterilization o Ethylene Oxide Sterilization (ETO) o Formaldehyde Sterilization o Other Low-Temperature Sterilization • Radiation Sterilization • Filtration Sterilization • Other Equipment o Contract Sterilization Services Market • ETO Sterilization Services • Gamma Sterilization Services • E-Beam Sterilization Services • Steam Sterilization Services • Other Sterilization Services o Consumables and Accessories • Sterilization Indicators o Chemical Indicators o Biological Indicators • Packaging Accessories • Cleaning and Disinfection Products o Disinfectants • Disinfectants, By Product Type o Hand Disinfectants o Surface Disinfectants o Skin Disinfectants o Instrument Disinfectants • Disinfectants, By Formulation o Disinfectant Wipes o Liquid Disinfectants o Disinfectant Sprays • Disinfectants, By EPA Classification o Low-Level Disinfectants o Intermediate-Level Disinfectants o High-Level Disinfectants o Cleaning and Disinfection Equipment • Washer Disinfectors • Flusher Disinfectors • UV-Ray Disinfectors • Ultrasonic Cleaners • Other Cleaning and Disinfection Equipment o Lubricants and Cleaning Solutions o Disinfection and Cleaning Accessories • Protective Barriers o Medical Nonwovens • Surgical Drapes • Surgical Gowns • Face Masks o Covers and Closures o Goggles o Gloves • Endoscope Reprocessing Products o Endoscope Reprocessing Consumables o Endoscope Reprocessing Equipment • Automated Endoscope Reprocessors • Endoscope Tracking Systems o Other Endoscope Reprocessing Products • Other Infection Control Products By End-User Hospitals & Clinics Medical Device Companies Pharmaceutical Companies Life Sciences Industry Food Industry Other End Users By Region North America Europe Asia Pacific Latin America Middle East & Africa Objectives of the Study: To provide with an exhaustive analysis on the global infection control market by product & services, by end-user, and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Infection Control Market to value over USD 54.3 billion and register a CAGR of over 3.2% during the forecast period of 2020-2027.
The rise in geriatric population along with the widening prevalence of chronic diseases due to lifestyle changes, sedentary habits, unhealthy dietary routines will drive future market growth. The population is thus more prone to acquiring infections due to the presence of a combination of increased comorbid condition and decreasing efficiency of the immune system.
The increasing frequency of surgical procedures coupled with the growing incidence of nosocomial infections will boost infection control market growth during the forecast period. Considering the statistics by WHO, 10 out of every 100 individuals hospitalized globally in developing countries and 7 in developed countries are likely to acquire nosocomial infections. The statistics accurately reflect the swelling need for the market’s products and services.
The market is classified into products & services, end-users, and region. In the products and services segment, the market is anticipated to grow at a lucrative rate throughout the forecast period. This accelerated increase is attributed to the high affinity of market players to diminish overall healthcare expenditure along maximizing patient benefits.
In context to end-users, hospitals and clinics held a principal share and are predicted to achieve growth at the highest CAGR throughout the forecast period. The substantial share is majorly a consequence of high probability of acquiring infections in hospital premises through respiratory or bloodborne pathogen transmission.
Based on the region, the Asia Pacific market is presumed to register the fastest growth during the projected time period with the surge in healthcare expenditure and superlative healthcare standards and infrastructure. Boost in the number of outsourcing organizations in the region will benefit the market in the forthcoming years. A voluntary organization, Asia Pacific Society of Infection Control (APSIC) entertains collaborations and partnerships as well as infection control research to promote cost-efficient practices throughout the region. The regional market also gains momentum on the back of various government organizations committed to elevating the standards for infection control.
Impact of COVID-19 on Infection Control Market:
According to WHO, the transmission of the COVID-19 is through respiratory droplets, i.e. droplets that are larger than 5 micrometers of diameter, and through contact route. With countries like India going under complete lockdown, the transmission of infection shall be curbed down significantly. Furthermore, hospitals are providing optimum healthcare services like creation of isolation wards for the infected patients, using PPE kits to treat the infected patients whilst avoiding getting infected. They also use EPA-certified surface disinfectants to clean the hospital premises.
Major industry players include:
3M Company, Belimed, Ahlstrom Corporation, Johnson & Johnson, Sterigenics International, Kimberly Clark Corporation, Steris, Getinge Group, Matachana Group, Cantel Medical Corporation.
Competitive Landscape:
Infection Control Market Segmentation:
By Product & Service • Sterilization Products and Services o Sterilization Equipment • Heat Sterilization Equipment o Moist Heat Sterilizers o Dry Heat Sterilizers • Low-Temperature Sterilization o Hydrogen Peroxide Sterilization o Ethylene Oxide Sterilization (ETO) o Formaldehyde Sterilization o Other Low-Temperature Sterilization • Radiation Sterilization • Filtration Sterilization • Other Equipment o Contract Sterilization Services Market • ETO Sterilization Services • Gamma Sterilization Services • E-Beam Sterilization Services • Steam Sterilization Services • Other Sterilization Services o Consumables and Accessories • Sterilization Indicators o Chemical Indicators o Biological Indicators • Packaging Accessories • Cleaning and Disinfection Products o Disinfectants • Disinfectants, By Product Type o Hand Disinfectants o Surface Disinfectants o Skin Disinfectants o Instrument Disinfectants • Disinfectants, By Formulation o Disinfectant Wipes o Liquid Disinfectants o Disinfectant Sprays • Disinfectants, By EPA Classification o Low-Level Disinfectants o Intermediate-Level Disinfectants o High-Level Disinfectants o Cleaning and Disinfection Equipment • Washer Disinfectors • Flusher Disinfectors • UV-Ray Disinfectors • Ultrasonic Cleaners • Other Cleaning and Disinfection Equipment o Lubricants and Cleaning Solutions o Disinfection and Cleaning Accessories • Protective Barriers o Medical Nonwovens • Surgical Drapes • Surgical Gowns • Face Masks o Covers and Closures o Goggles o Gloves • Endoscope Reprocessing Products o Endoscope Reprocessing Consumables o Endoscope Reprocessing Equipment • Automated Endoscope Reprocessors • Endoscope Tracking Systems o Other Endoscope Reprocessing Products • Other Infection Control Products
By End-User
By Region
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Infection Control Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Global Infection Control Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Infection Control Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Infection Control Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Infection Control Market, By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Sterilization Products and Services 7.1.1. Sterilization Equipment 7.1.1.1. Heat Sterilization Equipment 7.1.1.1.1. Moist Heat Sterilizers 7.1.1.1.2. Dry Heat Sterilizers 7.1.1.2. Low-Temperature Sterilization 7.1.1.2.1. Hydrogen Peroxide Sterilization 7.1.1.2.2. Ethylene Oxide Sterilization (ETO) 7.1.1.2.3. Formaldehyde Sterilization 7.1.1.2.4. Other Low-Temperature Sterilization 7.1.1.3. Radiation Sterilization 7.1.1.4. Filtration Sterilization 7.1.1.5. Other Equipment 7.1.2. Contract Sterilization Services Market 7.1.2.1. ETO Sterilization Services 7.1.2.2. Gamma Sterilization Services 7.1.2.3. E-Beam Sterilization Services 7.1.2.4. Steam Sterilization Services 7.1.2.5. Other Sterilization Services 7.1.3. Consumables and Accessories 7.1.3.1. Sterilization Indicators 7.1.3.1.1. Chemical Indicators 7.1.3.1.2. Biological Indicators 7.1.3.2. Packaging Accessories 7.2. Cleaning and Disinfection Products 7.2.1. Disinfectants 7.2.1.1. Disinfectants, By Product Type 7.2.1.1.1. Hand Disinfectants 7.2.1.1.2. Surface Disinfectants 7.2.1.1.3. Skin Disinfectants 7.2.1.1.4. Instrument Disinfectants 7.2.1.2. Disinfectants, By Formulation 7.2.1.2.1. Disinfectant Wipes 7.2.1.2.2. Liquid Disinfectants 7.2.1.2.3. Disinfectant Sprays 7.2.1.3. Disinfectants, By EPA Classification 7.2.1.3.1. Low-Level Disinfectants 7.2.1.3.2. Intermediate-Level Disinfectants 7.2.1.3.3. High-Level Disinfectants 7.2.2. Cleaning and Disinfection Equipment 7.2.2.1. Washer Disinfectors 7.2.2.2. Flusher Disinfectors 7.2.2.3. UV-Ray Disinfectors 7.2.2.4. Ultrasonic Cleaners 7.2.2.5. Other Cleaning and Disinfection Equipment 7.2.3. Lubricants and Cleaning Solutions 7.2.4. Disinfection and Cleaning Accessories 7.3. Protective Barriers 7.3.1. Medical Nonwovens 7.3.1.1. Surgical Drapes 7.3.1.2. Surgical Gowns 7.3.1.3. Face Masks 7.3.2. Covers and Closures 7.3.3. Goggles 7.3.4. Gloves 7.4. Endoscope Reprocessing Products 7.4.1. Endoscope Reprocessing Consumables 7.4.2. Endoscope Reprocessing Equipment 7.4.2.1. Automated Endoscope Reprocessors 7.4.2.2. Endoscope Tracking Systems 7.4.3. Other Endoscope Reprocessing Products 7.5. Other Infection Control Products 8. Global Infection Control Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Hospitals & Clinics 8.2. Medical Device Companies 8.3. Pharmaceutical Companies 8.4. Life Sciences Industry 8.5. Food Industry 8.5. Other End Users 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Mexico 10.2.3. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 13.1. 3M Company 13.1.1. Company Overview 13.1.2. Product Portfolio 13.1.3. SWOT Analysis 13.1.4. Financial Overview 13.1.5. Strategic Overview 13.2. Belimed 13.2.1. Company Overview 13.2.2. Product Portfolio 13.2.3. SWOT Analysis 13.2.4. Financial Overview 13.2.5. Strategic Overview 13.3. Ahlstrom Corporation 13.3.1. Company Overview 13.3.2. Product Portfolio 13.3.3. SWOT Analysis 13.3.4. Financial Overview 13.3.5. Strategic Overview 13.4. Johnson & Johnson 13.4.1. Company Overview 13.4.2. Product Portfolio 13.4.3. SWOT Analysis 13.4.4. Financial Overview 13.4.5. Strategic Overview 13.5 Sterigenics International 13.5.1. Company Overview 13.5.2. Product Portfolio 13.5.3. SWOT Analysis 13.5.4. Financial Overview 13.5.5. Strategic Overview 13.6 Kimberly Clark Corporation 13.6.1. Company Overview 13.6.2. Product Portfolio 13.6.3. SWOT Analysis 13.6.4. Financial Overview 13.6.5. Strategic Overview 13.7. Steris 13.7.1. Company Overview 13.7.2. Product Portfolio 13.7.3. SWOT Analysis 13.7.4. Financial Overview 13.7.5. Strategic Overview 13.8. Getinge Group 13.8.1. Company Overview 13.8.2. Product Portfolio 13.8.3. SWOT Analysis 13.8.4. Financial Overview 13.8.5. Strategic Overview 13.9. Matachana Group 13.9.1. Company Overview 13.9.2. Product Portfolio 13.9.3. SWOT Analysis 13.9.4. Financial Overview 13.9.5. Strategic Overview 13.10. Cantel Medical Corporation 13.10.1. Company Overview 13.10.2. Product Portfolio 13.10.3. SWOT Analysis 13.10.4. Financial Overview 13.10.5. Strategic Overview 14. Impact of COVID-19 14.1. Positive influence on the healthcare industry 14.2. The financial disruption of the manufacturing sector 14.3. Impact of COVID-19 on emerging companies 14.4. Significant mandates in the healthcare regulations initiated by administrations 14.5. The overall economic slowdown of the developing and developed nations 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics